These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 38825906
21. Primary NTRK-rearranged spindle cell neoplasm of bone harboring an HMBOX1::NTRK3 gene fusion. Wang Z, Wang J. Genes Chromosomes Cancer; 2023 Aug; 62(8):477-482. PubMed ID: 36740981 [Abstract] [Full Text] [Related]
22. Myxoid Spindle Cell Sarcoma With LMNA-NTRK Fusion: Expanding the Morphologic Spectrum of NTRK-Rearranged Tumors. So YK, Chow C, To KF, Chan JKC, Cheuk W. Int J Surg Pathol; 2020 Aug; 28(5):574-578. PubMed ID: 32050835 [Abstract] [Full Text] [Related]
23. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research. Marchiò C, Scaltriti M, Ladanyi M, Iafrate AJ, Bibeau F, Dietel M, Hechtman JF, Troiani T, López-Rios F, Douillard JY, Andrè F, Reis-Filho JS. Ann Oncol; 2019 Sep 01; 30(9):1417-1427. PubMed ID: 31268127 [Abstract] [Full Text] [Related]
24. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements. Tsai JW, Lee JC, Hsieh TH, Huang SC, Lee PH, Liu TT, Kao YC, Chang CD, Weng TF, Li CF, Lin JC, Liang CW, Su YL, Chang IY, Wang YT, Chang NY, Yu SC, Wang JC, Huang HY. Mod Pathol; 2022 Jul 01; 35(7):911-921. PubMed ID: 35149769 [Abstract] [Full Text] [Related]
25. Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls. Moura MS, Costa J, Velasco V, Kommoss F, Oliva E, Le Loarer F, McCluggage WG, Razack R, Treilleux I, Mills A, Longacre T, Devouassoux-Shisheboran M, Hostein I, Azmani R, Blanchard L, Hartog C, Soubeyran I, Khalifa E, Croce S. Histopathology; 2024 Feb 01; 84(3):451-462. PubMed ID: 37988282 [Abstract] [Full Text] [Related]
26. Case report: Adult NTRK-rearranged spindle cell neoplasms with TPM3-NTRK1 fusion in the pelvic. Cao Q, Huang Z, Liang H, Hu X, Wang L, Yang Y, Lian B, Huang J, Guo J. Front Oncol; 2024 Feb 01; 14():1308916. PubMed ID: 38357202 [Abstract] [Full Text] [Related]
32. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas. Nozaki Y, Yamamoto H, Iwasaki T, Sato M, Jiromaru R, Hongo T, Yasumatsu R, Oda Y. Hum Pathol; 2020 Dec 01; 106():82-92. PubMed ID: 32980422 [Abstract] [Full Text] [Related]
33. NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS. Zito Marino F, Buono S, Montella M, Giannatiempo R, Messina F, Casaretta G, Arpino G, Vita G, Fiorentino F, Insabato L, Sgambato A, Orditura M, Franco R, Accardo M. J Pathol Clin Res; 2023 Sep 01; 9(5):367-377. PubMed ID: 37143440 [Abstract] [Full Text] [Related]
34. Identifying patients with NTRK fusion cancer. Solomon JP, Benayed R, Hechtman JF, Ladanyi M. Ann Oncol; 2019 Nov 01; 30 Suppl 8():viii16-viii22. PubMed ID: 32223934 [Abstract] [Full Text] [Related]
35. Fluorescent In Situ Hybridization Must be Preferred to pan-TRK Immunohistochemistry to Diagnose NTRK3-rearranged Gastrointestinal Stromal Tumors (GIST). Castillon M, Kammerer-Jacquet SF, Cariou M, Costa S, Conq G, Samaison L, Douet-Guilbert N, Marcorelles P, Doucet L, Uguen A. Appl Immunohistochem Mol Morphol; 2021 Sep 01; 29(8):626-634. PubMed ID: 33758144 [Abstract] [Full Text] [Related]